METASTATIC HEAD AND NECK CANCER
Clinical trials for METASTATIC HEAD AND NECK CANCER explained in plain language.
Never miss a new study
Get alerted when new METASTATIC HEAD AND NECK CANCER trials appear
Sign up with your email to follow new studies for METASTATIC HEAD AND NECK CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy aims to supercharge immune system against HPV cancer
Disease control CompletedThis study tested whether adding a new immunotherapy called PDS0101 to an existing drug (pembrolizumab) could better treat advanced head and neck cancer caused by HPV16. It involved 95 adults whose cancer had returned or spread. The goal was to see if the combination could help t…
Matched conditions: METASTATIC HEAD AND NECK CANCER
Phase: PHASE2 • Sponsor: PDS Biotechnology Corp. • Aim: Disease control
Last updated Mar 30, 2026 14:34 UTC
-
New drug combo tested for Tough-to-Treat head and neck cancer
Disease control CompletedThis study tested a combination of two drugs, duvelisib and docetaxel, for people with advanced head and neck cancer that had returned or spread after their first treatment stopped working. The goal was to see if this new combination could help control the cancer. About 26 people…
Matched conditions: METASTATIC HEAD AND NECK CANCER
Phase: PHASE2 • Sponsor: Glenn J. Hanna • Aim: Disease control
Last updated Mar 19, 2026 14:56 UTC